Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.

Doerrbecker J, Behrendt P, Mateu-Gelabert P, Ciesek S, Riebesehl N, Wilhelm C, Steinmann J, Pietschmann T, Steinmann E.

J Infect Dis. 2013 Jan 15;207(2):281-7. doi: 10.1093/infdis/jis677. Epub 2012 Nov 5.

2.

Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.

Pouget ER, Hagan H, Des Jarlais DC.

Addiction. 2012 Jun;107(6):1057-65. doi: 10.1111/j.1360-0443.2011.03765.x. Epub 2012 Apr 17. Review.

3.

Hepatitis C virus vaccines among people who inject drugs.

Cox AL, Thomas DL.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S46-50. doi: 10.1093/cid/cit329. Review.

4.

Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.

Scott N, Hellard M, McBryde ES.

Virulence. 2016;7(2):201-8. doi: 10.1080/21505594.2015.1085151. Epub 2015 Aug 25. Review.

5.

Hepatitis C virus transmission dynamics in injection drug users.

Hagan H.

Subst Use Misuse. 1998 Apr;33(5):1197-212. Review.

PMID:
9596383
6.

Health care-associated hepatitis C virus infection.

Pozzetto B, Memmi M, Garraud O, Roblin X, Berthelot P.

World J Gastroenterol. 2014 Dec 14;20(46):17265-78. doi: 10.3748/wjg.v20.i46.17265. Review.

7.

Correlates of hepatitis C virus infections among injection drug users.

Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE.

Medicine (Baltimore). 1995 Jul;74(4):212-20. Review.

8.

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L.

Lancet. 2011 Aug 13;378(9791):571-83. doi: 10.1016/S0140-6736(11)61097-0. Epub 2011 Jul 27. Review.

9.

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, Hutchinson SJ.

Int J Drug Policy. 2014 Jan;25(1):34-52. doi: 10.1016/j.drugpo.2013.07.001. Epub 2013 Aug 21. Review.

PMID:
23973009
10.

A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

Hagan H, Pouget ER, Des Jarlais DC.

J Infect Dis. 2011 Jul 1;204(1):74-83. doi: 10.1093/infdis/jir196. Review.

11.

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.

Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ; International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3).

Lancet Infect Dis. 2012 May;12(5):408-14. doi: 10.1016/S1473-3099(12)70010-5. Review.

12.

Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y.

J Viral Hepat. 2015 Mar;22(3):213-29. doi: 10.1111/jvh.12337. Epub 2014 Oct 1. Review.

13.

Evolving epidemiology of hepatitis C virus in the United States.

Klevens RM, Hu DJ, Jiles R, Holmberg SD.

Clin Infect Dis. 2012 Jul;55 Suppl 1:S3-9. doi: 10.1093/cid/cis393. Review.

PMID:
22715211
14.

Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.

Corson S, Greenhalgh D, Palmateer N, Weir A, Hutchinson S.

Int J Drug Policy. 2011 Mar;22(2):102-8. doi: 10.1016/j.drugpo.2010.10.007. Epub 2010 Nov 26. Review.

PMID:
21112759
15.

HCV routes of transmission: what goes around comes around.

Alter MJ.

Semin Liver Dis. 2011 Nov;31(4):340-6. doi: 10.1055/s-0031-1297923. Epub 2011 Dec 21. Review.

PMID:
22189974
16.

Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.

Leask JD, Dillon JF.

Aliment Pharmacol Ther. 2016 Jul;44(2):145-56. doi: 10.1111/apt.13673. Epub 2016 May 20. Review.

PMID:
27199103
17.

Hidden hazards of HCV transmission.

Pondé RA.

Med Microbiol Immunol. 2011 Feb;200(1):7-11. doi: 10.1007/s00430-010-0159-9. Epub 2010 May 12. Review.

PMID:
20461405

Supplemental Content

Support Center